Wireless Tv Is So Main Stream
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by:Brian C. Barnes and Bailey R. Arenberg
GOTV STREAMING, LLC V. NETFLIX, INC.
Before Prost, Clevenger, and Taranto. Appeal from the United States District Court for the Central District of California.
Summary: A winning claim construction isn’t always enough to overcome § 101.
GoTV Streaming, LLC sued Netflix, Inc. for infringement of three patents directed to methods and systems for delivering and tailoring server content for streaming on wireless devices. Netflix argued that each patent was directed to ineligible subject matter under § 101. The district court rejected Netflix’s § 101 challenge but held all asserted claims of one of GoTV’s patents indefinite. A jury found that Netflix infringed the two remaining patents. GoTV and Netflix filed cross appeals on indefiniteness and patent eligibility.
On appeal, the Federal Circuit first reversed the district court’s indefiniteness holding, instead adopting GoTV’s proposed construction of the claim term. The court then turned to the two-step Alice test and held that, under step one, the claims were directed to the abstract idea of a template set of specifications that can be tailored for final production of a specified product to fit a user’s constraints. The court likened the abstract idea in the claims to a “pattern specifying many but not all details for a dress or trousers” or a “kitchen-cabinet blueprint.” At Alice step two, the court held that the claims lacked an inventive concept because they merely recited ordinary computers and networks collecting information to prepare a tailored image description for display on a device screen. Therefore, the Federal Circuit reversed the district court’s judgment on patentability and ruled in favor of Netflix.
Editor: Sean Murray
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…